Psilocybin and psilocin research index

Select for export

Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols

Details DOI 10.1016/j.euroneuro.2025.112746 PubMed 41546918 Copy citation Copy BibTeX

European Neuropsychopharmacology 2026-01-15 Damian Świeczkowski, Aleksander Kwaśny, Krzysztof Sadko, Wiesław Jerzy Cubała

OpenAlex Published psilocybin DepressionChronic PainClinical Trial Clinical Trial Psilocybin More

Select for export

P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status

Details DOI 10.1016/j.euroneuro.2021.10.394 Copy citation Copy BibTeX

European Neuropsychopharmacology 2021-11-30 Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle

OpenAlex Published psilocybin DepressionConsciousnessSafety Other Psilocybin More

Select for export

P.0885 The effect of psilocybin therapy for depression on low-frequency brain activity in response to music

Details DOI 10.1016/j.euroneuro.2021.10.741 Copy citation Copy BibTeX

European Neuropsychopharmacology 2021-11-30 Matthew B. Wall, Cynthia Lam, Natalie Ertl, Mendel Kaelen, Leor Roseman, David Nutt

OpenAlex Published psilocybin DepressionReceptor Pharmacology Other Glucocorticoid receptor More

Select for export

P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature review

Details DOI 10.1016/j.euroneuro.2021.10.797 Copy citation Copy BibTeX

European Neuropsychopharmacology 2021-11-30 Sara Penedos, Caio Freitas Ramos, María José López Miguel, Márcio José Martins Alves, Luciana Campos Paulino, Adriano Valério S. Azevêdo

OpenAlex Published psilocybin DepressionEating DisordersReview Article Review Article Psilocybin More

Select for export

P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Details DOI 10.1016/j.euroneuro.2019.09.593 Copy citation Copy BibTeX

European Neuropsychopharmacology 2019-11-30 Laura Mertens, M.B. Wall, L. Roseman, L. Demetriou, D.J. Nutt, R.L. Carhart-Harris

OpenAlex Published psilocybin DepressionMechanism of ActionEmotional Processing Clinical Trial Psilocybin More

Select for export

Psilocybin induces aberrant prediction error processing for tactile mismatch responses

Details DOI 10.1016/j.euroneuro.2018.11.477 Copy citation Copy BibTeX

European Neuropsychopharmacology 2018-12-31 P. Dürler

OpenAlex Published psilocybin DepressionAnxietyAddiction Other Baclofen More

Select for export

P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers

Details DOI 10.1016/s0924-977x(15)30364-3 Copy citation Copy BibTeX

European Neuropsychopharmacology 2015-08-31 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli

OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other Psilocybin More

Select for export

P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosis

Details DOI 10.1016/s0924-977x(03)92355-8 Copy citation Copy BibTeX

European Neuropsychopharmacology 2003-09-30 Felix Hasler, Ulrike Grimberg, Martin Benz, F.X. Vollenweider

OpenAlex Published psilocybin DepressionAddictionPharmacology Other rs4680 More